Clinical Trial Update: A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.

View source ↗

Summary

A clinical trial update describing the safety study of BESPONSA (inotuzumab ozogamicin) in pediatric patients with acute lymphoblastic leukemia, currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Besponsa (inotuzumab ozogamicin)

Snippet

Sponsor: Pfizer | Conditions: Acute Lymphocytic Leukemia | Status: ACTIVE_NOT_RECRUITING